Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

331 ARTÍCULOS , VIENDO DEL 106 AL 120

Plant alkaloids as drug leads for Alzheimer's disease

Ng YP, Or TC, Ip NY.

Neurochem Int. 2015 Oct;89:260-70. doi: 10.1016/j.neuint.2015.07.018. Epub 2015 Jul 26.

Perspectives on Inhibiting β-Amyloid Aggregation through Structure-Based Drug Design

Mishra P, Ayyannan SR, Panda G.

ChemMedChem. 2015 Sep;10(9):1467-74. doi: 10.1002/cmdc.201500215. Epub 2015 Jul 24.

Alzheimer's disease treated with combined therapy based on nourishing marrow and reinforcing Qi

Chen S, Yao X, Liang Y, Mei W, Liu X, Zhang C.

J Tradit Chin Med. 2015 Jun;35(3):255-9. doi: 10.1016/s0254-6272(15)30094-7.

Linking insulin with Alzheimer's disease: emergence as type III diabetes

Ahmed S, Mahmood Z, Zahid S.

Neurol Sci. 2015 Oct;36(10):1763-9. doi: 10.1007/s10072-015-2352-5. Epub 2015 Aug 7.

Alzheimer's in 3D culture: challenges and perspectives

D'Avanzo C, Aronson J, Kim YH, Choi SH, Tanzi RE, Kim DY.

Bioessays. 2015 Oct;37(10):1139-48. doi: 10.1002/bies.201500063. Epub 2015 Aug 7.

Inhibitory effect of chloroquine derivatives on presenilin 1 and ubiquilin 1 expression in Alzheimer's disease

Zhang FF, Li J.

Int J Clin Exp Pathol. 2015 Jun 1;8(6):7640-3. eCollection 2015.

From Bitopic Inhibitors to Multitarget Drugs for the Future Treatment of Alzheimer's Disease

Pérez DI, Martínez A, Gil C, Campillo NE.

Curr Med Chem. 2015;22(33):3789-806. doi: 10.2174/0929867322666150812145825.

Unfolded Protein Response and PERK Kinase as a New Therapeutic Target in the Pathogenesis of Alzheimer's Disease

Rozpedek W, Markiewicz L, Diehl JA, Pytel D, Majsterek I.

Curr Med Chem. 2015;22(27):3169-84. doi: 10.2174/0929867322666150818104254.

Involvement of inflammation in Alzheimer's disease pathogenesis and therapeutic potential of anti-inflammatory agents

Shadfar S, Hwang CJ, Lim MS, Choi DY, Hong JT.

Arch Pharm Res. 2015 Dec;38(12):2106-19. doi: 10.1007/s12272-015-0648-x. Epub 2015 Aug 21.

Long-term effectiveness of rivastigmine patch or capsule for mild-to-severe Alzheimer's disease: a meta-analysis

Su J, Liu Y, Liu Y, Ren L.

Expert Rev Neurother. 2015;15(9):1093-103. doi: 10.1586/14737175.2015.1068120. Epub 2015 Aug 6.

Early investigational drugs targeting tau protein for the treatment of Alzheimer's disease

Anand K, Sabbagh M.

Expert Opin Investig Drugs. 2015;24(10):1355-60. doi: 10.1517/13543784.2015.1075002. Epub 2015 Aug 1.

Nerve Growth Factor Gene Therapy: Activation of Neuronal Responses in Alzheimer Disease

Tuszynski MH, Yang JH, Barba D, U HS, Bakay RA, Pay MM, Masliah E, Conner JM, Kobalka P, Roy S, Nagahara AH.

JAMA Neurol. 2015 Oct;72(10):1139-47. doi: 10.1001/jamaneurol.2015.1807.

Treated Behavioral Symptoms and Mortality in Medicare Beneficiaries in Nursing Homes with Alzheimer's Disease and Related Dementias

Huang TY, Wei YJ, Moyo P, Harris I, Lucas JA, Simoni-Wastila L.

J Am Geriatr Soc. 2015 Sep;63(9):1757-65. doi: 10.1111/jgs.13606. Epub 2015 Aug 27.

Alzheimer's Disease: Genomics and Beyond

Song F, Han G, Bai Z, Peng X, Wang J, Lei H.

Int Rev Neurobiol. 2015;121:1-24. doi: 10.1016/bs.irn.2015.05.001. Epub 2015 Jun 19.

The Impact of Docosahexaenoic Acid on Alzheimer's Disease: Is There a Role of the Blood-Brain Barrier?

Pan Y, Khalil H, Nicolazzo JA.

Curr Clin Pharmacol. 2015;10(3):222-41. doi: 10.2174/157488471003150820151532.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias